BIOSENSE WEBSTER INC CARTO VIZIGO 8.5F BI-DIRECTIONAL GUIDING SHEATH - SMALL; INTRODUCER, CATHETER
|
Back to Search Results |
|
Model Number D138501 |
Device Problems
Partial Blockage (1065); Material Separation (1562)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 11/23/2020 |
Event Type
malfunction
|
Manufacturer Narrative
|
If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
|
|
Event Description
|
It was reported that a patient underwent a cardiac ablation procedure for atrial fibrillation (afib) with a carto vizigo¿ 8.5f bi-directional guiding sheath - small where a hemostatic valve separation issue and an inadequate irrigation issue occurred.It was reported that the carto vizigo¿ 8.5f bi-directional guiding sheath - small was unable to be flushed properly while in the left atrium (la).Initially the sheath flushed properly but once it got into the la, they were not able to flush it anymore.At that point, bleed back was noticed coming from the proximal part of the sheath.The sheath was replaced, and the issue was resolved.Hemostatic valve separation was not seen.No sections were showing visible breaks or separations.The hemostatic valve did not appear to be broken in 2 pieces.No air entered the patient¿s body.No percutaneous or surgical removal was required.Hemodynamics of the patient were not compromised due to bleed back.No medical intervention was needed to stop the bleeding.There was no report of thrombus or patient consequence.The hemostatic valve issue was assessed as a mdr reportable hemostatic valve separation.In addition, the inadequate irrigation issue was also assessed as mdr reportable.
|
|
Manufacturer Narrative
|
The bwi product analysis lab received the device for evaluation on (b)(6) 2021.The device evaluation was completed on (b)(6) 2021.It was reported that a patient underwent a cardiac ablation procedure for atrial fibrillation (afib) with a carto vizigo¿ 8.5f bi-directional guiding sheath - small where a hemostatic valve separation issue and an inadequate irrigation issue occurred.It was reported that the carto vizigo¿ 8.5f bi-directional guiding sheath - small was unable to be flushed properly while in the left atrium (la).Initially the sheath flushed properly but once it got into the la, they were not able to flush it anymore.At that point, bleed back was noticed coming from the proximal part of the sheath.The sheath was replaced, and the issue was resolved.Hemostatic valve separation was not seen.No sections were showing visible breaks or separations.The hemostatic valve did not appear to be broken in 2 pieces.No air entered the patient¿s body.No percutaneous or surgical removal was required.Hemodynamics of the patient were not compromised due to bleed back.No medical intervention was needed to stop the bleeding.There was no report of thrombus or patient consequence.The device was visually inspected and the hemostatic valve was found dislodged into the hub.It was determined that the issue observed could be related to the incorrect insertion of the dilator into the sheath causing the dislodgment of the valve since stress marks and physical damage on the outer diameter were observed under microscope which suggest that excessive force was applied.According to the odp (optimal performance guide), there are some precautions on inserting the dilator into the vizigo sheath - always insert a dilator straight into the center of the sheath¿s valve to prevent damage to the valve.- do not insert a dilator at an angle, as damage to the sheath valve may occur.A device history review was performed for the finished device, and no internal actions related to the complaint was found during the review.The issue reported by the customer was confirmed.It appears to be related to the incorrect introduction of the vessel dilator.The odp (optimal device performance guide) provides additional instructions on how to insert the dilator into the sheath.In addition, there is evidence that the device was manufactured in accordance with documented specification and procedures.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
|
Search Alerts/Recalls
|
|
|